The Correlation Between Expression of Apoptosis-Related Proteins and Myocardial Functional Reserve Evaluated by Dobutamine Stress Echocardiography in Patients with Dilated Cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 16, Issue 9, 2003, Pages 931-936

  Ho, Yi Lwun ^a   Chen, Chi Long ^b   Hsu, Ron Bin ^b   Lin, Lung Chun ^a   Huang, Por Jau ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS RELATED PROTEIN; DOBUTAMINE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HEART CONTRACTION; HEART DILATATION; HEART FUNCTION; HEART FUNCTIONAL RESERVE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NICK END LABELING; PROTEIN EXPRESSION; STRESS ECHOCARDIOGRAPHY;

EID: 0242467861     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-7317(03)00424-3     Document Type: Article

References (24)

1. Sabban HN, Sharov VG. Apoptosis in heart failure. Prog Cardiovasc Dis 1998;40:549-62.
2. Sabban HN, Sharov VG, Goldstein S. Programmed cell death in the progression of heart failure. Ann Med 1998;30:33-8.
3. Narula J, Haider N, Virmani K, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 1996;335:1182-9.
4. Olivetti G, Abbi K, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. New Engl J Med 1997;336:1131-4.
5. Schaper J, Lorenz-Meyer S, Suzuki K. The role of apoptosis in dilated cardiomyopathy. Herz 1999;24:219-24.
6. Drozdz J, Krzeminska-Pakula M, Plewka M, Ciesielczyk M, Kasprzak JD. Prognostic value of low dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy. Chest 2002;121:1216-22.
7. Kitaoka H, Takata J, Yabe T, Hitomi N, Furuno T, Doi YL. Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart 1999;81:523-7.
8. Dubois-Rande JL, Merlet P, Roudot F, Benvenuti C, Adnot S, Hittinger L, et al. Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J 1992;124:679-85.
9. Ho YL, Lin LC, Yen RF, Wu CC, Chen MF, Huang PJ. Significance of dobutamine-induced ST-segment elevation and T-wave pseudo-normalization in patients with Q-wave myocardial infarction: simultaneous evaluation by dobutamine stress echocardiography and thallium-201 SPECT. Am J Cardiol 1999;84:125-9.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
11. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
12. Amanullah AM, Chaudhry FA, Heo J, Galatro K, Dourdoufis P, Brozena S, et al. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for detecting contractile reserve and myocardial ichemia in ischemic cardiomyopathy. Am J Cardiol 1999;84:626-31.
13. Kao HL, Wu CC, Ho YL, Chen WJ, Lee CM, Chen MF, et al. Dobutamine stress echocardiography predicts early wall motion improvement after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;76:652-6.
14. Ho YL, Wu CC, Huang PJ, Lin LC, Chieng PU, Chen WJ, et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 1998;135:655-62.
15. Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 1999;29:380-6.
16. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999;99:2757-64.
17. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999;96:8144-9.
18. Narula J, Kolodgie FD, Virmani R. Apoptosis and cardiomyopathy. Curr Opin Cardiol 2000;15:183-8.
19. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
20. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-92.
21. Francis GS, Anwar F, Bank AJ, Kubo SH, Jessurun J. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human hearts: observations made after implantation of left ventricular assist device. J Card Fail 1999;5:308-15.
22. Song H, Conte JV Jr, Foster AH, McLaughlin JS, Wei C. Increased p53 protein expression in human failing myocardium. J Heart Lung Transplant 1999;18:744-9.
23. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-33.
24. Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999;104:239-52.